NCT03069638View on ClinicalTrials.gov

Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

December 18, 2023

Study Completion Date

December 18, 2023

Conditions
Juvenile Idiopathic ArthritisJoint Inflammation
Interventions
DRUG

Dexmedetomidine

Intranasal administration of dexmedetomidine as a procedural sedation (intra-articular joint injection)

DRUG

Sedatives/Hypnotics,Other

Inhaled dinitrous oxide as procedural sedation (intra-articular joint injection)

Trial Locations (1)

Unknown

Oulu university hospital, Oulu

All Listed Sponsors
lead

University of Oulu

OTHER

NCT03069638 - Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population | Biotech Hunter | Biotech Hunter